Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
Keyword(s):
Phase 3
◽
2015 ◽
Vol 72
(5)
◽
pp. AB251
2016 ◽
Vol 6
(4)
◽
pp. 639-647
◽
2017 ◽
Vol 76
(6)
◽
pp. AB167